Form D Explorer

Form C-AR — Ignite Biomedical, Inc.

0001665160-25-000759 · filed 2025-04-24

Offering

Target: —
Maximum: —
Security type: —
Price per security: —
Deadline: —
Oversubscription: —

Issuer

Name: Ignite Biomedical, Inc.
CIK: 2045356
Entity: Corporation
Jurisdiction: DE
Address: 945 CONCORD STREET, SUITE 202
FRAMINGHAM, MA 01701
Phone: —

Most recent fiscal year financials

Total assets

$249,693

Cash

—

Short-term debt

$1,235,394

Long-term debt

$1,825,000

Revenues

—

COGS

—

Taxes paid

—

Net income

$-2,513,567

View original on SEC EDGAR.